Factors associated with health-related quality of life in patients with severe Guillain – Barré syndrome

References

• Ropper A H. The Guillain – Barré syndrome. N Engl J Med 1992; 326: 1130–1136
   PubMed Web of Science ®Google Scholar
• Meythaler J M. Rehabilitation of Guillain – Barré syndrome. Arch Phys Med Rehabil 1997; 78: 872–879
   PubMed Web of Science ®Google Scholar
• Hughes R A, Raphael J C, Swan A V, van Doorn P A. Intravenous immunoglobulin for Guillain – Barré syndrome. Cochrane Database Syst Rev 2006; 25, CD002063. (Update of Cochrane Database Syst Rev 2004;CD002063)
   Google Scholar
• Harel M, Shoenfeld Y. Intravenous immunoglobulin and Guillain – Barré syndrome. Clin Rev Allergy Immunol 2005; 29: 281–287
   PubMed Web of Science ®Google Scholar
• Vedeler C A, Wik E, Nyland H. The long term prognosis of Guillain – Barré syndrome. Evaluation of prognostic factors including plasma exchange. Acta Neurol Scand 1997; 95: 298–302
   PubMed Web of Science ®Google Scholar
• Bernsen R AJAM, de Jager A EJ, Schmitz P IM, van der Meche F GA. Long-term sensory deficit after Guillain – Barré syndrome. J Neurol 2001; 248: 483–486
   PubMed Web of Science ®Google Scholar
• Bernsen R AJAM, de Jager A EJ, van der Meche F GA, Suurmeijer T PBM. How Guillain – Barré patients experience their functioning after 1 year. Acta Neurol Scand 2005; 112: 51–56
   PubMed Web of Science ®Google Scholar
• Lennon S M, Koblar S, Hughes R AC, Goeller J, Riser A C. Reason for persistent disability in Guillain – Barré syndrome. Clin Rehabil 1993; 7: 1–8
   Google Scholar
• Hughes R A, Wijdicks E F, Benson E, Cornblath D R, Hahn A F, Meythaler J M, et al. Multidisciplinary Consensus Group. Supportive care for patients with Guillain – Barré syndrome. Arch Neurol 2005; 62: 1194–1198
   PubMed Web of Science ®Google Scholar
• Nicholas R, Playford E D, Thompson A J. A retrospective analysis of outcome in severe Guillain – Barré syndrome following combined neurological and rehabilitation management. Disabil Rehabil 2000; 22: 451–455
   PubMed Web of Science ®Google Scholar
• Zelig G, Ohry A, Shemesh Y, Bar-On Z, Blumen M, Brooks M E. The rehabilitation of patients with Guillain – Barré syndrome. Paraplegia 1988; 26: 250–254
   PubMedGoogle Scholar
• Garssen M PJ, Bussmann J BJ, Schmitz P IM, et al. Physical training and fatigue, fitness, and quality of life in Guillain–Barré syndrome and CIDP. Neurology 2004; 63: 2393–2395
   PubMed Web of Science ®Google Scholar
• Forsberg A, Press R, Einarsson U, de Pedro-Cuesta J, Holmqvist L W. Impairment in Guillain – Barré syndrome during the first 2 years after onset: a prospective study. J Neurol Sci 2004; 227: 131–138
   PubMed Web of Science ®Google Scholar
• Meythaler J M, Devivo M J, Braswell W C. Rehabilitation outcomes of patients who have developed Guillain – Barré syndrome. Am J Phys Med Rehabil 1997; 76: 411–419
   PubMed Web of Science ®Google Scholar
• Forsberg A, Press R, Einarsson U, de Pedro-Cuesta J, Holmqvist L W. Disability and health-related quality of life in Guillain – Barré syndrome during the first two years after onset: a prospective study. Clin Rehabil 2005; 19: 900–909
   PubMed Web of Science ®Google Scholar
• World Health Organization. International Classification of Functioning. Disability and Health. World Health Organization, Geneva 2001
   Google Scholar
• Bernsen R AJAM, Jacobs H M, de Jager A EJ, van der Meche F G. Residual health status after Guillain – Barré syndrome. J Neurol Neurosurg Psychiatr 1997; 62: 637–640
   PubMed Web of Science ®Google Scholar
• Bernsen R AJAM, de Jager A EJ, Schmitz P IM, van der Meche F GA. Long-term impact on work and private life after Guillain – Barré syndrome. J Neurol Sci 2002; 201: 13–17
   PubMed Web of Science ®Google Scholar
• Andresen E M, Meyers A R. Health-related quality of life outcomes measures. Arch Phys Med Rehabil 2000; 81(Suppl. 2)S30–S45
   PubMed Web of Science ®Google Scholar
• Asbury A K, Cornblath D R. Assessment of current diagnostic criteria for Guillain – Barré syndrome. Ann Neurol 1990; 27(Suppl.)S21–S24
   PubMed Web of Science ®Google Scholar
• Hughes R AC, Newson-Davis J M, Perkins G D, Pierce J M. Controlled trial of prednisolone in acute polyneuropathy. Lancet 1978; ii: 50–53
   Google Scholar
• Kücükdeveci A A, Yavuzer G, Elhan A H, Sonel B, Tennant A. Adaptation of the Functional Independence Measure for use in Turkey. Clin Rehabil 2001; 15: 311–319
   PubMed Web of Science ®Google Scholar
• Prasad R, Hellawell D J, Pentland B. Usefulness of the Functional Independence Measure (FIM), its subscales and individual items as outcome measure in Guillain – Barré syndrome. Int J Rehabil Res 2001; 24: 59–64
   PubMed Web of Science ®Google Scholar
• Kücükdeveci A A, McKenna S P, Kutlay S, Gürsel Y, Whalley D, Arasıl T. The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 2001; 23: 31–38
   Web of Science ®Google Scholar
• de Haan R, Aaronson N, Limburg M, Hower R L, van Crevel H. Measuring quality of life in stroke. Stroke 1993; 24: 320–327
   PubMed Web of Science ®Google Scholar
• Bernsen R AJAM, de Jager A EJ, Schmitz P IM, van der Meche F GA. Residual physical outcome and daily living 3 to 6 years after Guillain – Barré syndrome. Neurology 1999; 53: 409–410
   PubMed Web of Science ®Google Scholar
• Caroll A, McDonnell G, Barners M. A review of the management of Guillain – Barré syndrome in a regional neurological rehabilitation unit. Int J Rehabil Res 2003; 26: 297–302
   PubMed Web of Science ®Google Scholar
• Fuhrer M J, Rintala D H, Hart K A, Clearman R, Young M E. Relationship of life satisfaction to impairment, disability and handicap among person with spinal cord injury living in the community. Arch Phys Med Rehabil 1992; 73: 552–557
   PubMed Web of Science ®Google Scholar
• Merkies I S, Schmitz P I, van der Meche F G, Samijn J P, van Doorn P A. Connecting impairment, disability, and handicap in immune mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) group. J Neurol Neurosurg Psychiatr 2003; 74: 99–104
   PubMed Web of Science ®Google Scholar
• Fletcher D D, Lawn N DF, Wolter T D, Wijdicks E FM. Long-term outcome in Guillain – Barré syndrome requiring mechanical ventilation. Neurology 2000; 54: 2311–2315
   PubMed Web of Science ®Google Scholar
• Weiss H, Rastan V, Mullges W, Wagner R F, Toyka K V. Psychotic symptoms and emotional distress in patients with Guillain – Barré syndrome. Neurology 2002; 47: 74–78
   Web of Science ®Google Scholar
• Merkies I S, Schmitz P I, van der Meche F G, Samijn J P, van Doorn P A. Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) group. Neurology 2002; 59: 84–91
   PubMed Web of Science ®Google Scholar